Sageworth Trust Co Lowers stake in Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ) : Sageworth Trust Co reduced its stake in Johnson & Johnson by 4.11% during the most recent quarter end. The investment management company now holds a total of 6,256 shares of Johnson & Johnson which is valued at $780,561 after selling 268 shares in Johnson & Johnson , the firm said in a disclosure report filed with the SEC on Jul 26, 2016.Johnson & Johnson makes up approximately 0.18% of Sageworth Trust Co’s portfolio.

Other Hedge Funds, Including , British Airways Pensions Investment Management Ltd boosted its stake in JNJ in the latest quarter, The investment management firm added 272,913 additional shares and now holds a total of 744,394 shares of Johnson & Johnson which is valued at $92,878,039. Johnson & Johnson makes up approx 2.73% of British Airways Pensions Investment Management Ltd’s portfolio.Shell Asset Management Co boosted its stake in JNJ in the latest quarter, The investment management firm added 75,654 additional shares and now holds a total of 604,850 shares of Johnson & Johnson which is valued at $75,467,135. Johnson & Johnson makes up approx 1.74% of Shell Asset Management Co’s portfolio.Rothschild Investment Corp Il boosted its stake in JNJ in the latest quarter, The investment management firm added 51 additional shares and now holds a total of 58,354 shares of Johnson & Johnson which is valued at $7,296,001. Johnson & Johnson makes up approx 0.90% of Rothschild Investment Corp Il’s portfolio.Lvm Capital Management Ltdmi boosted its stake in JNJ in the latest quarter, The investment management firm added 69 additional shares and now holds a total of 115,533 shares of Johnson & Johnson which is valued at $14,193,229. Johnson & Johnson makes up approx 4.07% of Lvm Capital Management Ltdmi’s portfolio.Ckw Financial Group boosted its stake in JNJ in the latest quarter, The investment management firm added 5 additional shares and now holds a total of 643 shares of Johnson & Johnson which is valued at $78,993. Johnson & Johnson makes up approx 0.03% of Ckw Financial Group’s portfolio.

Johnson & Johnson opened for trading at $124.34 and hit $125.32 on the upside on Friday, eventually ending the session at $125.23, with a gain of 0.62% or 0.77 points. The heightened volatility saw the trading volume jump to 70,20,910 shares. Company has a market cap of $344,463 M.

On the company’s financial health, Johnson & Johnson reported $1.74 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.68. The company had revenue of $18482.00 million for the quarter, compared to analysts expectations of $17985.80 million. The company’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.71 EPS.

Investors should note that on Jul 20, 2016, Johnson & Johnson announced a cash dividend of $0.2900. The company’s management has announced Aug 3, 2016 as the ex-dividend date and fixed the record date on Aug 5, 2016. The payable date has been fixed on Aug 19, 2016.

Many Wall Street Analysts have commented on Johnson & Johnson. Company shares were Reiterated by UBS on Jul 20, 2016 to “Buy”, Firm has raised the Price Target to $ 137 from a previous price target of $126 .Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 133 from a previous price target of $125 .Standpoint Research Initiated Johnson & Johnson on May 20, 2016 to “Sell”, Price Target of the shares are set at $94.

Johnson & Johnson is a holding company. The Company is engaged in the research and development manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Company’s primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer Pharmaceutical and Medical Devices. The Company’s subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Company’s research facilities are located in the United States Belgium Brazil Canada China France Germany India Israel Japan the Netherlands Singapore Switzerland and the United Kingdom.

Leave a Reply

Johnson & Johnson - Is it time to Sell?

Top Brokerage Firms are advising their investors on Johnson & Johnson. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.